Don’t miss this informative webinar featuring an introduction and critical study of in vitro permeation testing (IVPT) as it applies to in vitro skin penetration studies, and information on related new U.S. Food and Drug Administration guidance. The presentation is sponsored by Teledyne Hanson, the leading global technology company specializing in analytical test instruments for the pharmaceutical industry for more than 70 years.
• Clive Roper, director of Roper Toxicology Consulting Ltd.
• Frank Toner, associate director of In Vitro Dermal Services at Charles River
Join us for an expert discussion of the what’s, why’s and how’s of bioequivalence testing of topical pharmaceuticals via (IVPT). The presentation will include vital information on draft guidance the FDA Office of Generics has provided, based on Acyclovir, to generate bioequivalence data without the use of clinical trials.
• What is IVPT?
• Why Perform IVPT?
• IVPT: The Five Steps
1. Analytical method development
2. Analytical method validation
3. IVPT method development
4. IVPT pilot
5. IVPT pivotal
Following the presentation, you’ll have a valuable and unique opportunity to gain expert answers to your questions specific to IVPT in your lab. Teledyne Hanson representative Bruna Lousada also will offer information on the company’s IVPT-related instruments, products and services.
About Teledyne Hanson
Teledyne Hanson has been the leading global technology company specializing in analytical test instruments for the pharmaceutical industry for more than 70 years. Our sensitive, accurate and reliable products include versatile dissolution test systems; diffusion cell testing instruments; and solutions for disintegration, power flowability, physical table testing, and sample preparation. Learn more at hansonresearch.com.